Protein-binding aptamers are widely used in biosensing and therapeutics, yet reliable solution-phase methods for validating aptamer binding remain limited. Here, we establish green fluorescent protein (GFP) as a self-reporting benchmark system for homogeneous analysis of aptamer-protein interactions. A previously identified GFP-binding DNA aptamer, GFP-1, was modified at the 3′ terminus with a fluorescence quencher, generating a dual-readout probe that simultaneously reports binding through fluorescence quenching and fluorescence polarization. The quencher modification preserved nanomolar affinity for GFP while producing a substantially more sensitive change than polarization alone. Using this probe, we developed a homogeneous competitive displacement assay that revealed overlapping binding sites among three distinct GFP aptamers. We further implemented a reverse-chase kinetic format which enabled the direct determination of apparent dissociation rate constants (koff) from solution-phase fluorescence traces. The kinetic ranking placed GFP-1 with the slowest dissociation and GFP-3 with the quickest. Both affinity and kinetic parameters were preserved in 10% human serum, demonstrating assay robustness in complex biological media. This fluorescence-based platform operates entirely in solution and provides a practical framework for validating aptamer-target interactions, measuring dissociation kinetics, and benchmarking aptamer assays under physiologically relevant conditions.
No takes yet. Share an insight, caveat, or question.
Stangherlin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: